NCT06538714 Interval Training and Cardio-metabolic Health in Overweight/Obese Girls
| NCT ID | NCT06538714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose |
| Condition | Exercise Overtraining |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2024-05-20 |
| Primary Completion | 2024-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2024-05-20 with a primary completion date of 2024-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main purpose of this study is to compare the impact of 12-week moderate-intensity interval training (MIIT) versus combined MIIT with high-intensity interval training (HIIT) on physical fitness, cardio metabolic, lipidomic, hematological and psychological characteristics in young overweight/obese girls.
Eligibility Criteria
Inclusion Criteria: * Female gender, * Overweight or obese according to the BMI classification, * Age, 12 to 15 years, * Personal or parental/guardian written consent Exclusion Criteria: * Severe infectious or inflammatory diseases, * Irregular menstrual cycles * Participation in organized exercise training in the last 6 months or additional physical - * recreational activities, except physical education classes. * Using medications, hormone therapy or dietary supplements
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06538714 clinical trial?
This trial is open to female participants only, aged 12 Years or older, up to 15 Years, studying Exercise Overtraining. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06538714 currently recruiting?
Yes, NCT06538714 is actively recruiting participants. Contact the research team at amani.kallel@fmt.utm.tn for enrollment information.
Where is the NCT06538714 trial being conducted?
This trial is being conducted at Tunis, Tunisia, Tunis, Tunisia.
Who is sponsoring the NCT06538714 clinical trial?
NCT06538714 is sponsored by Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose. The trial plans to enroll 45 participants.